Testing effectiveness (Phase 2)Study completedNCT00417807
What this trial is testing
Imatinib Mesylate in Patients With Refractory Desmoplastic Small Round Cell Tumors
Who this might be right for
Refractory Desmoplastic Small Round Cell Tumors
Novartis Pharmaceuticals 9